U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 105

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr18:29172878
GRCh38:
Chr18:31592915
TTRC30YAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr18:29172883
GRCh38:
Chr18:31592920
TTRL32VCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Feb 24, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr18:29172884
GRCh38:
Chr18:31592921
TTRL32Pnot specifiedPathogenic
(Jun 5, 2019)
criteria provided, single submitter
4.
GRCh37:
Chr18:29172901
GRCh38:
Chr18:31592938
TTRD38NAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr18:29172902
GRCh38:
Chr18:31592939
TTRD38GAmyloidogenic transthyretin amyloidosisPathogenic
(Jul 13, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr18:29172903
GRCh38:
Chr18:31592940
TTRD38EAmyloidogenic transthyretin amyloidosisPathogenic
(Nov 5, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr18:29172905
GRCh38:
Chr18:31592942
TTRA39DCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr18:29172907
GRCh38:
Chr18:31592944
TTRV40ICardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr18:29172908
GRCh38:
Chr18:31592945
TTRV40AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Jul 19, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr18:29172917
GRCh38:
Chr18:31592954
TTRS43NCardiovascular phenotype, Amyloidogenic transthyretin amyloidosis, not provided
Pathogenic/Likely pathogenic
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr18:29172919
GRCh38:
Chr18:31592956
TTRP44Snot provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Pathogenic
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr18:29172920
GRCh38:
Chr18:31592957
TTRP44LAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Oct 13, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr18:29172922
GRCh38:
Chr18:31592959
TTRA45SCardiovascular phenotypeLikely pathogenic
(Dec 5, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr18:29172922
GRCh38:
Chr18:31592959
TTRA45TAMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED, Amyloidogenic transthyretin amyloidosisPathogenic
(Apr 14, 2009)
no assertion criteria provided
15.
GRCh37:
Chr18:29172937
GRCh38:
Chr18:31592974
TTRV50LAmyloidogenic transthyretin amyloidosisPathogenic
(Jul 2, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr18:29172937
GRCh38:
Chr18:31592974
TTRV50LCardiovascular phenotype, Charcot-Marie-Tooth disease, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr18:29172937
GRCh38:
Chr18:31592974
TTRV50MAmyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1,
Cardiovascular phenotype, Charcot-Marie-Tooth disease, not provided,
Cardiomyopathy, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr18:29172938
GRCh38:
Chr18:31592975
TTRV50GAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 21, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr18:29172938
GRCh38:
Chr18:31592975
TTRV50AAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 18, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr18:29172944
GRCh38:
Chr18:31592981
TTRV52AAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeLikely pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr18:29172946
GRCh38:
Chr18:31592983
TTRF53LCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Jan 9, 2023)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr18:29172946
GRCh38:
Chr18:31592983
TTRF53IAmyloidogenic transthyretin amyloidosisPathogenic
(Feb 1, 1993)
no assertion criteria provided
23.
GRCh37:
Chr18:29172949
GRCh38:
Chr18:31592986
TTRR54GAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 12, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr18:29172950
GRCh38:
Chr18:31592987
TTRR54TAmyloidogenic transthyretin amyloidosisPathogenic
(Oct 14, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr18:29172952
GRCh38:
Chr18:31592989
TTRK55EAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Dec 21, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr18:29172954
GRCh38:
Chr18:31592991
TTRK55NAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 22, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr18:29172954
GRCh38:
Chr18:31592991
TTRK55Nnot provided, Amyloidogenic transthyretin amyloidosisLikely pathogenic
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr18:29172955
GRCh38:
Chr18:31592992
TTRA56PAmyloidogenic transthyretin amyloidosisPathogenic
(Jun 14, 2018)
no assertion criteria provided
29.
GRCh37:
Chr18:29172961
GRCh38:
Chr18:31592998
TTRD58HAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr18:29172962
GRCh38:
Chr18:31592999
TTRD58VAmyloidogenic transthyretin amyloidosisPathogenic
(Mar 5, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr18:29172962
GRCh38:
Chr18:31592999
TTRD58ACardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Sep 30, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr18:29172968
GRCh38:
Chr18:31593005
TTRT60NAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeLikely pathogenic
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr18:29172971
GRCh38:
Chr18:31593008
TTRW61LAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 2, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr18:29172974
GRCh38:
Chr18:31593011
TTRE62GAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 1, 1992)
no assertion criteria provided
35.
GRCh37:
Chr18:29172975
GRCh38:
Chr18:31593012
TTRE62DAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr18:29172980
GRCh38:
Chr18:31593017
TTRF64SCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr18:29172982
GRCh38:
Chr18:31593019
TTRA65Tnot provided, Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr18:29172983
GRCh38:
Chr18:31593020
TTRA65DAmyloidogenic transthyretin amyloidosis, not providedPathogenic/Likely pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr18:29172988
GRCh38:
Chr18:31593025
TTRAmyloidogenic transthyretin amyloidosisPathogenic
(Apr 1, 2000)
no assertion criteria provided
40.
GRCh37:
Chr18:29172988
GRCh38:
Chr18:31593025
TTRAmyloidogenic transthyretin amyloidosisPathogenic
(Apr 1, 2000)
no assertion criteria provided
41.
GRCh37:
Chr18:29172989
GRCh38:
Chr18:31593026
TTRG67VAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr18:29172989
GRCh38:
Chr18:31593026
TTRG67ECardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Sep 22, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr18:29172989
GRCh38:
Chr18:31593026
TTRG67ACardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr18:29175087
GRCh38:
Chr18:31595124
TTRT69AAmyloidogenic transthyretin amyloidosisPathogenic
(Feb 13, 1997)
no assertion criteria provided
45.
GRCh37:
Chr18:29175088
GRCh38:
Chr18:31595125
TTRT69IAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 26, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr18:29175088
GRCh38:
Chr18:31595125
TTRT69SAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 26, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr18:29175090
GRCh38:
Chr18:31595127
TTRS70GAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Oct 13, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr18:29175090
GRCh38:
Chr18:31595127
TTRS70RAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Aug 18, 2011)
criteria provided, single submitter
49.
GRCh37:
Chr18:29175091-29175092
GRCh38:
Chr18:31595128-31595129
TTRAmyloidogenic transthyretin amyloidosisPathogenic
(Mar 16, 2018)
no assertion criteria provided
50.
GRCh37:
Chr18:29175091
GRCh38:
Chr18:31595128
TTRS70IAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 31, 1992)
no assertion criteria provided
51.
GRCh37:
Chr18:29175092
GRCh38:
Chr18:31595129
TTRS70Rnot provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Pathogenic
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr18:29175092
GRCh38:
Chr18:31595129
TTRS70RCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr18:29175096
GRCh38:
Chr18:31595133
TTRS72PAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic
(Aug 17, 2017)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr18:29175099
GRCh38:
Chr18:31595136
TTRG73RAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
55.
GRCh37:
Chr18:29175100
GRCh38:
Chr18:31595137
TTRG73EAMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATEDPathogenic
(Jul 10, 2001)
no assertion criteria provided
56.
GRCh37:
Chr18:29175102-29175103
GRCh38:
Chr18:31595139-31595140
TTRE74LAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr18:29175102
GRCh38:
Chr18:31595139
TTRE74KCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr18:29175103
GRCh38:
Chr18:31595140
TTRE74AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
59.
GRCh37:
Chr18:29175103
GRCh38:
Chr18:31595140
TTRE74Gnot specified, Cardiovascular phenotype, not provided
Pathogenic/Likely pathogenic
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr18:29175105
GRCh38:
Chr18:31595142
TTRL75MAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 16, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr18:29175106
GRCh38:
Chr18:31595143
TTRL75RAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 31, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr18:29175106
GRCh38:
Chr18:31595143
TTRL75PAmyloidogenic transthyretin amyloidosisPathogenic
(Jan 1, 1997)
no assertion criteria provided
63.
GRCh37:
Chr18:29175111
GRCh38:
Chr18:31595148
TTRG77RAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 1, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr18:29175115
GRCh38:
Chr18:31595152
TTRL78RAmyloidogenic transthyretin amyloidosisPathogenic
(Oct 15, 1991)
no assertion criteria provided
65.
GRCh37:
Chr18:29175115
GRCh38:
Chr18:31595152
TTRL78HCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr18:29175117
GRCh38:
Chr18:31595154
TTRT79AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Apr 9, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr18:29175118
GRCh38:
Chr18:31595155
TTRT79Knot providedLikely pathogenic
(May 11, 2020)
criteria provided, single submitter
68.
GRCh37:
Chr18:29175120
GRCh38:
Chr18:31595157
TTRT80ACardiovascular phenotype, Charcot-Marie-Tooth disease, Cardiomyopathy,
not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr18:29175121
GRCh38:
Chr18:31595158
TTRT80IAmyloidogenic transthyretin amyloidosis, not provided, Cardiovascular phenotype
Pathogenic/Likely pathogenic
(Jun 29, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr18:29175123
GRCh38:
Chr18:31595160
TTRE81KCardiovascular phenotypeLikely pathogenic
(Jan 30, 2019)
criteria provided, single submitter
71.
GRCh37:
Chr18:29175124
GRCh38:
Chr18:31595161
TTRE81ACardiovascular phenotypeLikely pathogenic
(Mar 10, 2019)
criteria provided, single submitter
72.
GRCh37:
Chr18:29175126
GRCh38:
Chr18:31595163
TTRE82KCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Nov 29, 2021)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr18:29175132
GRCh38:
Chr18:31595169
TTRF84LCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis,
Carpal tunnel syndrome, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Jan 9, 2023)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr18:29175133
GRCh38:
Chr18:31595170
TTRF84YAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Jul 7, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr18:29175133
GRCh38:
Chr18:31595170
TTRF84SAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr18:29175134
GRCh38:
Chr18:31595171
TTRF84LCharcot-Marie-Tooth disease, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Mar 13, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr18:29175140
GRCh38:
Chr18:31595177
TTRE86DAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 6, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr18:29175141
GRCh38:
Chr18:31595178
TTRG87RAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Oct 13, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr18:29175144
GRCh38:
Chr18:31595181
TTRI88LAmyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1,
Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Jan 9, 2023)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr18:29175147
GRCh38:
Chr18:31595184
TTRY89HCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Jan 25, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr18:29175150
GRCh38:
Chr18:31595187
TTRK90QAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Apr 30, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr18:29175152
GRCh38:
Chr18:31595189
TTRK90NAmyloidogenic transthyretin amyloidosisPathogenic
(Nov 1, 1992)
no assertion criteria provided
83.
GRCh37:
Chr18:29175154
GRCh38:
Chr18:31595191
TTRV91AAmyloidogenic transthyretin amyloidosisPathogenic
(Feb 13, 1997)
no assertion criteria provided
84.
GRCh37:
Chr18:29175159
GRCh38:
Chr18:31595196
TTRI93VAmyloidogenic transthyretin amyloidosis, Hereditary amyloidosisPathogenic/Likely pathogenic
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr18:29175172
GRCh38:
Chr18:31595209
TTRS97FCardiovascular phenotypePathogenic
(Apr 30, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr18:29175172
GRCh38:
Chr18:31595209
TTRS97YCardiovascular phenotype, Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic,
Carpal tunnel syndrome 1, Charcot-Marie-Tooth disease, not specified,
not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr18:29175175
GRCh38:
Chr18:31595212
TTRY98FCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr18:29175193
GRCh38:
Chr18:31595230
TTRI104TAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr18:29175193
GRCh38:
Chr18:31595230
TTRI104SCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr18:29175205
GRCh38:
Chr18:31595242
TTRH108RCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Aug 18, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr18:29175207
GRCh38:
Chr18:31595244
TTRE109Knot provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Pathogenic/Likely pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr18:29175207
GRCh38:
Chr18:31595244
TTRE109QCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr18:29178543
GRCh38:
Chr18:31598580
TTRA117SCardiovascular phenotype, Carpal tunnel syndrome 1, Hyperthyroxinemia, dystransthyretinemic,
Amyloidogenic transthyretin amyloidosis, not provided, Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Sep 22, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr18:29178544
GRCh38:
Chr18:31598581
TTRA117DAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Dec 24, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr18:29178544
GRCh38:
Chr18:31598581
TTRA117GAmyloidogenic transthyretin amyloidosisPathogenic
(Jan 1, 1994)
no assertion criteria provided
96.
GRCh37:
Chr18:29178571
GRCh38:
Chr18:31598608
TTRT126NAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Mar 8, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr18:29178573
GRCh38:
Chr18:31598610
TTRI127VHyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis,
Cardiovascular phenotype, not specified, not provided,
Amyloidogenic transthyretin amyloidosis
Pathogenic/Likely pathogenic
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr18:29178575
GRCh38:
Chr18:31598612
TTRI127MAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr18:29178585
GRCh38:
Chr18:31598622
TTRL131MAmyloidogenic transthyretin amyloidosisPathogenic
(Oct 1, 1993)
no assertion criteria provided
100.
GRCh37:
Chr18:29178594
GRCh38:
Chr18:31598631
TTRY134HCarpal tunnel syndrome 1Pathogenic
(Feb 1, 1994)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination